Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07155148Recruiting
Argentine registry for Crohn's and colitis patients
This study collects information from people diagnosed with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. By joining the registry, you help researchers learn more about these conditions and improve care.
Córdoba, Córdoba ProvinceAges Any age - NCT07156773RecruitingPhase 2
Nasal spray for Parkinson's off episodes
This study tests a new nasal spray called XJN010 for people with Parkinson's who have 'off' episodes—times when their regular medication wears off and symptoms come back. The goal is to see if the spray can safely and effectively help during those periods.
Guangzhou, GuangdongAges 30–85 - NCT07157345RecruitingPhase 1
Testing PDR-001 for Parkinson's Disease
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
Shanghai, Shanghai MunicipalityAges 40–65 - NCT07157397Recruiting
Plant-based diet for nutrition on dialysis
This study tests if eating more plant-based foods can improve nutrition in people on peritoneal dialysis who are underweight or malnourished. Participants will follow a special diet plan and have regular health check-ups for 6 months.
Cheras, Kuala LumpurAges 18 years+ - NCT07157735RecruitingPhase 2
Testing an anti-inflammatory drug for early Parkinson's disease
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
CambridgeAges 50–80 - NCT07160231RecruitingPhase 4
Lowering dose of JAK inhibitors for rheumatoid arthritis or psoriatic arthritis
This trial tests if reducing the dose of a JAK inhibitor can keep your inflammatory arthritis under control. If you have rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis and are in a stable remission, you may be able to take a lower dose.
Nijmegen, GelderlandAges 16 years+ - NCT07163689Recruiting
TIPS for liver disease with portal hypertension
This trial compares patients who have a rare liver condition (porto-sinusoidal vascular disease) with those who have cirrhosis, to see how a procedure called TIPS (a shunt placed in the liver to reduce blood pressure) works for complications like bleeding, fluid buildup, or blood clots.
Amiens, PicardieAges 18 years+ - NCT07163858Recruiting
Leg raising vs. medication for heart bypass surgery
This trial compares a simple leg-raising technique to a medicine (noradrenaline) to help keep blood pressure stable during heart bypass surgery. It may help you avoid stronger drugs and have a smoother recovery.
Caluire-et-Cuire, Auvergne-Rhône-AlpesAges 18 years+ - NCT07165470Recruiting
Pre-packaged low-residue diet for IBD colonoscopy prep
This study tests whether a ready-to-eat low-residue diet (a diet that leaves very little waste in your colon) helps people with IBD prepare for a colonoscopy. It may make the prep easier and more effective than standard bowel-cleansing drinks.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07166757RecruitingPhase 1/Phase 2
Study of XS411 for early-onset Parkinson's disease
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07166731Recruiting
Carotid stent vs. medication for recent stroke risk
This trial tests if a carotid artery stent plus medication is better than medication alone at preventing another stroke in people who recently had a stroke or eye blockage caused by a non-narrowing but risky carotid plaque.
Solingen, North Rhine-WestphaliaAges 18 years+ - NCT07169045Recruiting
Stepper test for people with peripheral artery disease
This study checks if a 6-minute stepper test is a good way to measure walking ability in people with peripheral artery disease. You will step up and down for 6 minutes to see how far you can go.
Ankara, ÇankayaAges 18–80 - NCT07169578RecruitingPhase 3
A study of trontinemab for early Alzheimer's disease
This trial tests a new drug called trontinemab for people with early Alzheimer's disease. The goal is to see if it can help slow down memory and thinking problems.
Birmingham, AlabamaAges 50–90 - NCT07170150RecruitingPhase 3
A study of trontinemab for early Alzheimer's disease
This trial tests an investigational drug called trontinemab in people with early symptomatic Alzheimer's disease. It aims to see if it can slow down memory and thinking problems.
Phoenix, ArizonaAges 50–90 - NCT07170475RecruitingPhase 1
Study of febuxostat and inosine for Parkinson's disease
This trial tests whether a combination of two supplements, febuxostat and inosine, can help people with Parkinson's disease. It aims to see if this treatment is safe and may improve symptoms.
Toyoake, Aichi-kenAges 18–80 - NCT07171216Recruiting
Parathyroid hormone control and bone density in kidney disease
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
Herlev, Capital RegionAges 50 years+ - NCT07171905RecruitingPhase 2
Study of a new imaging agent for Von Hippel-Lindau disease
This trial tests a special imaging agent that targets a protein found in tumors related to Von Hippel-Lindau (VHL) disease. It may help doctors better detect and monitor these tumors.
Milan, ItaliaAges 18 years+ - NCT07172555Recruiting
Virtual diet check-ins for coeliac disease
This study tests if virtual appointments with a dietitian can help manage coeliac disease. It compares different ways of providing diet support to find what works best for patients.
Sheffield, South YorkshireAges 18 years+ - NCT07174622Recruiting
Long-term results for renal denervation study
This study tracks patients who have uncontrolled high blood pressure and are on a steady medication plan. It checks how kidney nerve treatment (renal denervation) works in real life over time.
Boston, MassachusettsAges 18 years+ - NCT07175909Recruiting
Tear analysis for dry eye diagnosis and management
This study looks at proteins in your tears to better understand and treat dry eye disease. You may qualify if you have dry eye symptoms and certain test results show your eyes are not functioning normally.
Hong KongAges 18–65 - NCT07176507Recruiting
Study of multiple and mixed heart valve disease
This study looks at people who have two or more heart valve problems that are moderate to severe. It aims to learn more about this condition and how to best manage it.
LilleAges 18 years+ - NCT07177833RecruitingPhase 1
Laser treatment for chronic Peyronie's disease
This trial tests a new type of laser treatment (fractional CO2 laser) to safely reduce penile curvature in men with chronic, stable Peyronie's disease. It may be an option if you have had the condition for at least a year with no recent changes or pain.
Ottawa, OntarioAges 18 years+ - NCT07177976Recruiting
Comparing two breathing exercises for COPD
This study compares two breathing techniques—Pilates breathing and pursed lip breathing—to see which one improves chest expansion and peak expiratory flow rate (how fast you can blow air out) in people with mild COPD.
RawalpindiAges 40–64 - NCT07178041Recruiting
Remote conditioning after hip fracture surgery
This study tests if a simple, non-invasive treatment using a blood pressure cuff on the arm can help reduce complications after hip fracture surgery. It might help improve recovery by preparing the body to handle the stress of surgery.
Sheffield, South YorkshireAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.